| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BIRB 0796 | GDSC1000 | pan-cancer | AAC | 0.062 | 0.08 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | 0.064 | 0.08 |
| mRNA | XMD8-85 | GDSC1000 | pan-cancer | AAC | 0.094 | 0.08 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | -0.055 | 0.08 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.08 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | 0.06 | 0.08 |
| mRNA | Salubrinal | GDSC1000 | pan-cancer | AAC | 0.095 | 0.08 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | 0.057 | 0.08 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.09 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.063 | 0.09 |